EUVIMEDEUVIMED entdecken
Crossref

Dual-function PROTAC suppresses ferroptosis and restores neuronal function via brain-targeted delivery

Tianyu Ma, Tianli Luo, Ming Wang

Cell Chemical Biology · 2026

DOI: 10.1016/j.chembiol.2026.06.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Chemical Biology, 2026. Verfasst von Tianyu Ma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Science, CAS Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese …. Hauptthemen laut MEDLINE: Ferroptosis, Brain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Beijing National Laboratory for Molecular Sciences, National Natural Science Foundation of China, Beijing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted protein degradation (TPD) via proteolysis-targeting chimeras (PROTACs) offers a promising strategy for modulating disease-associated proteins, yet effective brain-preferred protein degradation remains challenging. Herein, we report a dual-function PROTAC, dACSL4, and its nose-to-brain delivery for brain-preferred protein degradation and therapeutic suppression of ferroptosis in neurodegeneration. dACSL4 selectively degrades acyl-CoA synthetase long-chain family member 4 (ACSL4) while concurrently activating peroxisome proliferator-activated receptor γ (PPARγ), thereby coordinating lipid metabolism and oxidative stress to suppress neuronal ferroptosis. dACSL4 achieved up to 30-fold greater protection against neuronal ferroptosis compared to conventional ferroptosis inhibitors. Intranasal delivery of dACSL4 using biodegradable lipid nanoparticles (BAmP-TK12) enabled brain-preferred ACSL4 degradation and PPARγ activation, reducing lipid peroxidation and preserving dopaminergic neurons in a Parkinson's disease model, ultimately improving motor function. Our findings establish a modular strategy for brain-preferred protein degradation and highlight the therapeutic potential of dual-function degraders for ferroptosis suppression in neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisBrainAnimalsProteolysis Targeting ChimeraHumansMiceNanoparticlesPPAR gammaCoenzyme A LigasesParkinson DiseaseProteolysisNeuronsMice, Inbred C57BL

Stichwörter der Autor:innen

DeliveryPROTACdual-function PROTACferroptosislipid nanoparticlesneurodegenerationtargeted protein degradation

Substanzen

Proteolysis Targeting ChimeraPPAR gammaCoenzyme A Ligases

Autor:innen und Institutionen

  • Beijing National Laboratory for Molecular Science, CAS Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Acad…

Förderung

  • Beijing National Laboratory for Molecular Sciences
  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation

Zitieren

APA

Ma, T., Luo, T., & Wang, M. (2026). Dual-function PROTAC suppresses ferroptosis and restores neuronal function via brain-targeted delivery. Cell Chemical Biology. https://doi.org/10.1016/j.chembiol.2026.06.010

Vancouver

Ma T, Luo T, Wang M. Dual-function PROTAC suppresses ferroptosis and restores neuronal function via brain-targeted delivery. Cell Chemical Biology. 2026. doi:10.1016/j.chembiol.2026.06.010

BibTeX
@article{Ma2026,
  author = {Ma, Tianyu and Luo, Tianli and Wang, Ming},
  title = {Dual-function PROTAC suppresses ferroptosis and restores neuronal function via brain-targeted delivery},
  journal = {Cell Chemical Biology},
  year = {2026},
  doi = {10.1016/j.chembiol.2026.06.010}
}
Kostenlos starten →